ska-31 has been researched along with riluzole in 1 studies
*Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS. [MeSH]
*Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busch, C; Hoyer, J; Köhler, R; Raman, G; Sankaranarayanan, A; Schultz, T; Wulff, H; Zimin, PI | 1 |
1 other study(ies) available for ska-31 and riluzole
| Article | Year |
|---|---|
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Topics: Animals; Benzothiazoles; Biological Factors; Blood Pressure; Endothelium; Intermediate-Conductance Calcium-Activated Potassium Channels; Mice; Potassium Channels | 2009 |